Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Autoimmune Encephalitis
NCT06033846Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Oct 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline in Autoimmune Encephalitis (AE), sponsored by Xijing Hospital. Started Oct 2023; status: completed.
02
Drugs
minocycline
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on NCT06033846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033846.